Real-world effectiveness of the Bright Bodies healthy lifestyle intervention for childhood obesity

被引:6
|
作者
Samuels, Stephanie L. [1 ,4 ]
Hu, Pamela [1 ]
Maciejewski, Kaitlin R. [2 ]
Li, Fangyong [2 ]
Dziura, James [2 ]
Savoye, Mary [1 ]
Sharifi, Mona [3 ]
机构
[1] Yale Univ, Dept Pediat, Sect Endocrinol Diabet & Metab, Sch Med, New Haven, CT USA
[2] Yale Univ, Yale Ctr Analyt Sci, Sch Publ Hlth, New Haven, CT USA
[3] Yale Univ, Yale Ctr Implementat Sci, Ctr Med Informat, Dept Pediat,Sect Gen Pediat,Sch Med, New Haven, CT USA
[4] Yale Univ, Dept Pediatr, Sect Endocrinol & Diabet, Sch Med, 333 Cedar St, POB 208064, New Haven, CT 06520 USA
基金
美国国家卫生研究院;
关键词
WEIGHT MANAGEMENT PROGRAM; DIABETES PREVENTION; Z-SCORES; CHILDREN; ADOLESCENTS; PREVALENCE; PREDICTORS; OUTCOMES; IMPACT; AGE;
D O I
10.1002/oby.23627
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectiveThis study aimed to examine the extent to which Bright Bodies, a high-intensity, family-based pediatric weight management intervention, improved BMI for participants since publication of the randomized controlled trial establishing efficacy in 2007 and to describe adaptations to the program. MethodsFor participants enrolled from 2008 to 2018, linear mixed-effects models were used to estimate monthly change in BMI expressed as percentage of the 95th percentile (%BMIp95) during participants' first beginner-level program. ResultsThe sample included 396 youth individuals (mean age: 11.7 [SD 2.8] years, 61.6% female, 37.1% non-Hispanic Black, 26.3% Hispanic or Latino, 53.8% with public insurance, 80.1% with severe obesity). Across the 11 years, participants' %BMIp95 reduced on average by 1.63% (95% CI: 1.44%-1.82%) per month during their first program (mean duration: 10 weeks) after adjusting for age, sex, season and year, starting %BMIp95, race and ethnicity, and insurance category. Greater reduction in %BMIp95 was associated with male versus female sex, spring/fall versus winter seasons, enrollment in 2008 to 2018 versus 2015 to 2018, and higher starting %BMIp95 (p value for all <0.001). Adaptations since 2007 included pragmatic changes to increase engagement and address funding shortages. ConclusionsThese results suggest sustained clinical effectiveness of Bright Bodies in the context of real-world adaptations.
引用
收藏
页码:203 / 213
页数:11
相关论文
共 50 条
  • [31] A real-world evaluation of a tertiary care childhood obesity intervention to reduce metabolic risk in a hard-to-reach urban population
    Bayoumi, Nagla S.
    Helzner, Elizabeth
    Afable, Aimee
    Joseph, Michael A.
    Dhuper, Sarita
    BMC PEDIATRICS, 2019, 19 (01)
  • [32] A real-world evaluation of a tertiary care childhood obesity intervention to reduce metabolic risk in a hard-to-reach urban population
    Nagla S. Bayoumi
    Elizabeth Helzner
    Aimee Afable
    Michael A. Joseph
    Sarita Dhuper
    BMC Pediatrics, 19
  • [33] How to measure real-world effectiveness?
    Launois, R.
    Trouiller, J. -B.
    Cabout, E.
    ANNALES PHARMACEUTIQUES FRANCAISES, 2018, 76 (06): : 421 - 435
  • [34] REAL-WORLD EFFECTIVENESS OUTCOMES FOR URETHROPLASTY
    Goldfarb, Robert
    Brandes, Steven
    Kirk, Peter
    Borza, Tudor
    Qin, Yongmei
    Skolarus, Ted
    JOURNAL OF UROLOGY, 2017, 197 (04): : E660 - E660
  • [35] Real-world effectiveness of Ergonomic methods
    MacLeod, IS
    APPLIED ERGONOMICS, 2003, 34 (05) : 465 - 477
  • [36] Real-world effectiveness and safety of alirocumab
    Mondelo Garcia, C.
    Garcia Queiruga, M.
    Balea Filgueiras, J.
    Fernandez Bargiela, N.
    Gimenez Arufe, V.
    Fernandez Oliveira, C.
    Martin Herranz, M. I.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (01) : 377 - 378
  • [37] Comparative Effectiveness and Real-World Evidence
    Leonard, Daniel T.
    AMERICAN JOURNAL OF MANAGED CARE, 2010, 16 (06): : 410 - 411
  • [38] REAL-WORLD BOARD TEST EFFECTIVENESS
    SCHLOTZHAUER, EO
    IEEE DESIGN & TEST OF COMPUTERS, 1988, 5 (02): : 16 - 23
  • [39] Effectiveness and tolerability of orlistat and liraglutide in patients with obesity in a real-world setting: The XENSOR Study
    Gorgojo-Martinez, Juan J.
    Basagoiti-Carreno, Belen
    Sanz-Velasco, Alberto
    Serrano-Moreno, Clara
    Almodovar-Ruiz, Francisca
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2019, 73 (11)
  • [40] Cost effectiveness of a controlled lifestyle intervention for pregnant women with obesity
    Gyllensten, Hanna
    Haby, Karin
    Berg, Marie
    Premberg, Asa
    BMC PREGNANCY AND CHILDBIRTH, 2021, 21 (01)